No abstract available
Keywords:
SGLT2 inhibitors; cancer; cardio-oncology; cardio-toxicity; heart failure.
MeSH terms
-
Antineoplastic Agents* / adverse effects
-
Heart Diseases*
-
Heart Failure*
-
Humans
-
Neoplasms* / drug therapy
-
Sodium-Glucose Transporter 2 Inhibitors* / adverse effects
Substances
-
Sodium-Glucose Transporter 2 Inhibitors
-
Antineoplastic Agents